[Primary CNS lymphoma in azathioprine therapy for autoimmune diseases: review of the literature and case report].
We present a 31-year-old female patient with primary non-Hodgkin's lymphoma of the CNS after immunosuppressive therapy. Colitis ulcerosa had been diagnosed 2 years previously. Prophylactic therapy with azathioprine over 9 months was stopped after the development of listeria meningitis which was treated successfully with antibiotics. At this time native CCT was normal. Three months later the patient developed an epileptic seizure and multiple cerebral lesions were detected in CCT and MRI. Although antibiotic therapy was started, the cerebral lesions showed no regression. Stereotactic biopsy revealed immunochemical and histologic high-grade malignant B cell lymphoma. The risk of primary CNS lymphoma under azathioprine treatment for an autoimmune disease with a possible congenital immunodeficiency is presented and the literature is reviewed.
Kästner
F
F
Klinik und Poliklinik für Neurologie, Universitätsklinikum, Albert-Schweitzer-Strasse 33, 48129 Münster. Florian.Kaestner@ukmuenster.de
Paulus
W
W
Deckert
M
M
Schlegel
P
P
Evers
S
S
Husstedt
I W
IW
D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000139:chemically induced* / Q000175:diagnosis*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced* / Q000175:diagnosis*
D007166:Immunosuppressive Agents; D001379:Azathioprine